PillarRx Consulting, LLC Completes a Successful Data Validation Season
PillarRx has released its 2021 Data Validation Customer Survey results, achieving a 5-star rating due to exceptional service in quality, audit accuracy, and actionable reporting. With a 99% customer retention rate since 2011, 100% of respondents expressed strong satisfaction, indicating likely continued use of PillarRx’s services in 2022. Innovations such as updated automation processes and improved communication with PBMs contributed to success. Additionally, the company secured 11 new contracts for 2022, highlighting its robust reputation and client relationships.
- Achieved a 5-star rating in the 2021 Data Validation Customer Survey.
- 100% customer retention with continued service utilization expected in 2022.
- Secured 11 additional contracts for 2022.
- Innovations in automation and communication lead to improved service efficiency.
- None.
MILWAUKEE, Sept. 21, 2021 /PRNewswire/ -- PillarRx is pleased to present the results of our 2021 Data Validation Customer Survey. After each season it is important for us to see how our DV program performed for our clients. The survey allows us to quantify service levels and how our process and program can better serve our customers.
This year, PillarRx's Data Validation program received a 5-star rating. Our responses unanimously showed extreme satisfaction with this year's quality, value, and the data validation process of PillarRx and Account Management team. PillarRx continued to exceed customer expectations from an audit accuracy, timeliness, and actional reporting.
While preparing for each DV season, PillarRx reviews the previous year's audits and new CMS guidelines. Key to this year's 5-star rating were making the following improvements for better serving our clients:
- Updated automation of the recalculation process.
- Reduced the number of meetings with PBMs and MTM providers by discussing all policies and procedures of their plans, instead of holding individual calls. This improvement saved time for the PBMs, vendors, and our clients.
- Better understanding, year-over-year of CMS measures, specifically Improving Drug Utilization Review Controls (IDURC).
Listening to the feedback provided by our Medicare Part C & D Program customers and adjusting processes, has helped achieve a
2021 Successes
Following DV audits, PillarRx presents each final report findings and recommendations. These individual meetings allow for open dialogue between all parties, provides an update on any new guidelines for the following year, and if applicable, a plan for making adjustments to the client's current Medicare Part D Program offering.
After completing all final report meetings, PillarRx was honored to receive an additional 11 contracts starting in 2022! Our success can be measured by what our clients think of us!
"Our PillarRx auditors were great to work with and answered all our questions or addressed issues in a timely manner."
"Very professional. Very thorough. Working with our PillarRx auditor was very seamless."
"Your company did a great job and provided an easy-to-understand instructions and answered questions and addressed issues in a timely manner."
"Pillar Rx is extremely organized, professional and helpful."
If you or a client offer a Medicare Part C and/or D Program, contact PillarRx for more information about our data validation services at sales@pillarrx.com or visit our webpage here.
Media Contact:
marketing@pillarrx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/pillarrx-consulting-llc-completes-a-successful-data-validation-season-301381610.html
SOURCE PillarRx Consulting, LLC
FAQ
What were the results of PillarRx's 2021 Data Validation Customer Survey?
How has PillarRx performed in customer retention?
What innovations contributed to PillarRx's success in 2021?
How many new contracts did PillarRx secure for 2022?
What feedback did clients provide regarding PillarRx's data validation services?
